Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces

Journal of Environmental Monitoring

Volumn 6, Issue 12, 2004, Pages 979-984

  Hedmer, Maria ^a   Jönsson, Bo A G ^a   Nygren, Olle ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

AIR SAMPLING; ARTICLE; CONTAMINATION; DESORPTION; ENVIRONMENTAL MONITORING; FILTER; HOSPITAL PHARMACY; LIQUID CHROMATOGRAPHY; MEASUREMENT; PRIORITY JOURNAL; ROOM TEMPERATURE; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; WORKPLACE;

AIR POLLUTANTS, OCCUPATIONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; ENVIRONMENTAL MONITORING; HOSPITALS; HUMANS; OCCUPATIONAL EXPOSURE; PHARMACIES; REPRODUCIBILITY OF RESULTS; WORKPLACE;

EID: 10944222119     PISSN: 14640325     EISSN: None     Source Type: Journal    
DOI: 10.1039/b409277e     Document Type: Article

References (26)

1. P. J. Sessink, N. S. Friemel, R. B. Anzion and R. P. Bos, Int. Arch. Occup. Environ. Health, 1994, 65, 401.
2. A. S. Ensslin, A. Pethran, R. Schierl and G. Fruhmann, Int. Arch. Occup. Environ. Health, 1994, 65, 339.
3. A. S. Ensslin, Y. Stoll, A. Pethran, A. Pfaller, H. Rommelt and G. Fruhmann, Occup. Environ. Med., 1994, 51, 229.
4. P. J. Sessink, J. L. Timmersmans, R. B. Anzion and R. P. Bos, J. Occup. Med., 1994, 36, 79.
5. A. Pethran, R. Schierl, K. Hauff, C. H. Grimm, K. S. Boos and D. Nowak, Int. Arch. Occup. Environ. Health, 2003, 76, 5.
6. O. Nygren and C. Lundgren, Int. Arch. Occup. Environ. Health, 1997, 70, 209.
7. N. Brock, Cancer Res., 1989, 49, 1.
8. International Agency for Research on Cancer, IARC monographs on the evaluation of the carcinogenic risk to humans. Vol 26. Some antineoplastic and immunosuppressive agents, Lyon, France, 1981.
9. International Agency for Research on Cancer, IARC monographs on the evaluation of the carcinogenic risk to humans. Suppl. 7. Overall evaluation of carcinogenicity: An updating of IARC monographs volumes 1-42, Lyon, France, 1987.
10. P. J. Sessink, R. B. Anzion. P. H. Van den Broek and R. P. Bos, Pharm. Weekbl. Sci., 1992, 14, 16.
11. J. J. McDevitt, P. S. Lees and M. A. McDiarmid, J. Occup. Med., 1993, 35, 57.
12. T. H. Conner. R. W. Anderson, P. J. Sessink, L. Broadfield and L. A. Power, Am. J. Health Syst. Pharm., 1999, 56, 1427.
13. C. Minoia, R. Turci, C. Sottani, A. Schiavi, L. Perbellini, S. Angeleri, F. Draicchio and P. Apostoli, Rapid Commun. Mass. Spectrom., 1998, 12, 1485.
14. A. Pethran, R. Schierl and G. Schmaus, Krankenhauspharmazie, 2001, 22, 11.
15. G. Schmaus, R. Schierl and S. Funck. Am. J. Health Syst. Pharm., 2002, 59, 956.
16. R. R. Larson, M. B. Khazaeli and H. K. Dillon, Am. J. Health Syst. Pharm., 2002, 59, 270.
17. A. de Werk Neal, R. A. Wadden and W. L. Chiou, Am. J. Hosp. Pharm., 1983, 40, 597.
18. L. Pyy, M. Sorsa and E. Hakala, Am. Ind. Hyg. Assoc. J., 1988, 49, 314.
19. M. Sorsa, L. Pyy, S. Salomaa, L. Nylund and J. W. Yager, Mutat. Res., 1988, 204, 465.
20. S. Opiolka, W. Mölter, R. Goldschmidt, E. Erich and G. Schöppe, Krankenhaus Technik, 1998, 56.
21. T. K. Kiffmeyer, C. Kube, S. Opiolka, K. G. Schmidt, G. Schöppe and P. J. M. Sessink, Pharm. J., 2002, 268, 331.
22. R. R. Larson, M. B. Khazaeli and H. K. Dillon, Appl. Occup. Environ. Hyg., 2003, 18, 120.
23. K. Andersson, J.-O. Levin. R. Lindahl and C.-A. Nilsson, Chemosphere, 1984, 13, 437.
24. J.-O. Levin, R. Lindahl and K. Andersson, Environ. Sci. Technol., 1986, 20, 1273.
25. AFS 1999:11, Cytostatika och andra läkemedel med bestående toxisk effekt [Cylostaticsand other drugs with permanent toxic effects], The Swedish Work Environment Authority, Solna, Sweden, 1999.
26. J. C. Miller and J. N. Miller, Statistics for Analytical Chemistry, 3rd edn., Ellis Horwood, Chichester, UK, p. 115.